Specialty Areas: Heart failure
Chronology: MSN: Vanderbilt University, Nurse Practitioner, 1994; Acute Care Nurse Practitioner; Board Certified Adult Nurse Practitioner, 2006; Board Certified Registered Nurse, 2015.
Jana Glotzer’s focus is on the prevention and treatment of cardiovascular disease through direct patient care and clinical research. With more than 30 years experience as a critical care provider, she has educated and treated inpatient and outpatient heart failure patients. Jana has also served as a key research coordinator and project manager for multiple heart failure studies at the University of North Carolina.
Evolution of biomarker guided therapy for heart failure: current concepts and trial evidence. Pruett AE, Lee AK, Patterson JH, Schwartz TA, Glotzer JM, Adams KF Jr. Curr Cardiol Rev. 2015;11(1):80-9. Review.
Trastuzumab-induced cardiotoxicity. Moss LS, Starbuck MF, Mayer DK, Harwood EB, Glotzer J. Oncol Nurs Forum. 2009 Nov;36(6):676-85. doi: 10.1188/09.ONF.676-685. Review.
Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Keteyian SJ, Isaac D, Thadani U, Roy BA, Bensimhon DR, McKelvie R, Russell SD, Hellkamp AS, Kraus WE; HF-ACTION Investigators. Am Heart J. 2009 Oct;158(4 Suppl):S72-7. doi: 10.1016/j.ahj.2009.07.014.
Outcomes, health policy, and managed care: relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure. Flynn KE, Lin L, Ellis SJ, Russell SD, Spertus JA, Whellan DJ, Piña IL, Fine LJ, Schulman KA, Weinfurt KP; HF-ACTION Investigators. Am Heart J. 2009 Oct;158(4 Suppl):S64-71. doi: 10.1016/j.ahj.2009.07.010.
Prediction of rehospitalization and death in severe heart failure by physicians and nurses of the ESCAPE trial. Yamokoski LM, Hasselblad V, Moser DK, Binanay C, Conway GA, Glotzer JM, Hartman KA, Stevenson LW, Leier CV. J Card Fail. 2007 Feb;13(1):8-13.